Patents Examined by Alyssa M. Alter
  • Patent number: 11559685
    Abstract: An adapter system connects to implantable electrode leads. The adapter system has the pulse generator configured to generate electrical stimulation pulses and has a first connector member. The adapter has a housing containing two receptacles. Each receptacle receives an end portion of an electrode lead to establish an electrical connection between the adapter and the electrode lead. The adapter contains a second connector member configured to engage with the first connector member to establish a mechanical connection between the housing and the pulse generator and an electrical connection between the pulse generator and the electrode lead. A test cable electrically connects the pulse generator to the electrode leads for testing the electrode leads. The test cable contains a first connector member configured to engage with the second connector member to establish an electrical connection. The test cable contains a second connector member configured to engage with the first connector member.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: January 24, 2023
    Assignee: BIOTRONIK SE & Co. KG
    Inventors: David McIntosh, Andrew B. Kibler, Lauren Kraiter
  • Patent number: 11547864
    Abstract: An implantable medical device system is configured to sense cardiac events in response to a cardiac electrical signal crossing a cardiac event sensing threshold. A control circuit is configured to determine a drop time interval based on a heart rate and control a sensing circuit to hold the cardiac event sensing threshold at a threshold value during the drop time interval.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: January 10, 2023
    Assignee: Medtronic, Inc.
    Inventors: Jian Cao, Gerald P. Arne, Timothy A. Ebeling, Yanina Grinberg, Michael W. Heinks, Paul R. Solheim, Xusheng Zhang
  • Patent number: 11534610
    Abstract: A method of downregulating and/or upregulating neural activity by applying a high frequency alternating current electrical signal to a nerve in a subject is disclosed. The signal comprises more than one microsecond cycle comprising one or more periods, each period comprising a charge recharge phase, and optionally, a pulse delay, each period having a frequency of at least 1000 Hz; and a microsecond inactive phase. In embodiments, an electrical signal treatment comprises more than one microsecond cycle to form a millisecond cycle, each millisecond cycle separated by a millisecond inactive phase during an on time. In embodiments, the electrical signal patterns can differ in amplitude.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: December 27, 2022
    Assignee: ReShape Lifesciences Inc.
    Inventors: Jonathan J. Waataja, Adrianus P. Donders
  • Patent number: 11534609
    Abstract: The invention comprises providing electric stimuli, which are generated by forming the following ringing circuit: active electrode—inductive storage unit—passive electrode—interelectrode tissues—active electrode, the electric stimuli creating oscillations which are used as a test signal. In one variant of the method, the electrodes are successively applied (in another variant—moved uniformly) across the skin area. Every time the electrodes-to-skin contact is detected, the oscillation parameters are recorded after a delay. Moreover, the values of parameters can be averaged. The invention allows for both combined and disjointed (i.e. separated) electrode placement. An optimal zone for electropulse therapy is identified by a minimal or maximal value of one or more parameters of the aforementioned oscillations and the use of the principle of small asymmetry. The invention further provides for an increase in the accuracy with which zones optimal for electropulse therapy are identified and localized.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: December 27, 2022
    Inventors: Yakov Zalmanovich Grinberg, Yury Yurievich Starovoytov, Mikhail Anatolievich Unakafov
  • Patent number: 11497909
    Abstract: Aspects of the invention include a computer-implemented method requiring loading, via a processor, a meridian tool into an electrical device having an input screen. The method causes, via the processor, the meridian tool to display a human body image on the input screen. The method receives, via the processor, input signals from the input screen to indicate pain points on the human body image and displays, via the processor, a pain level input display on the input screen. The method receives, via the processor, pain level input from the pain level input display screen and causes, via the processor, the electrical device to provide controlling electrical pulses to a meridian acupuncture sleeve, wherein the controlling electrical pulses controls the application of current being applied to electrical pads within the meridian acupuncture sleeve to provide pain relief for the pain points on the human body.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: November 15, 2022
    Inventor: Steven Ehrlich
  • Patent number: 11491335
    Abstract: A system for neuromodulation, at least including a timeline definition module configured to define a timeline in which neuromodulation may be provided; A timeline dividing module for dividing the timeline into a series of time slots; several neuromodulation entities, each entity being capable to claim at least one slot exclusively for providing neuromodulation.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: November 8, 2022
    Assignee: ONWARD MEDICAL N.V.
    Inventor: Johan Gerard Kleibeuker
  • Patent number: 11478647
    Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: October 25, 2022
    Assignee: MEDTRONIC, INC.
    Inventors: Michael L. Ellingson, Hyun J. Yoon
  • Patent number: 11464975
    Abstract: Methods and apparatuses to detect configuration commands from waveforms received at a retina prosthesis device for calibrating the device are described. The device can comprise an array of pixel units to receive light to stimulate neuron cells to cause an effect of visual sensation from the light. The pixel units may have configurable parameters for the stimulation to the neuron cells. The configurable parameters may be updated according to the configuration commands detected without requiring micro processor and non-volatile memory in the device. The stimulation may be generated according to the updated configurable parameters to improve the effect of visual sensation from the light including compensation for the physiological and environmental variations and drifts.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: October 11, 2022
    Assignee: IRIDIUM MEDICAL TECHNOLOGY CO., LTD.
    Inventor: Long-Sheng Fan
  • Patent number: 11464976
    Abstract: Modulation of neural activity of a ganglion, by applying a signal to a sympathetic nerve adjacent to the ganglion, results in preferential reduction of sympathetic signals to an effector, thereby providing ways of treating and preventing conditions associated with exacerbated sympatho-excitation.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: October 11, 2022
    Assignee: Galvani Bioelectronics Limited
    Inventors: Gerald Edwin Hunsberger, Arun Sridhar
  • Patent number: 11445983
    Abstract: An example method for estimating a disease state for a patient can include: capturing physiological data including images from the patient over time; processing the physiological data to detect a variability; comparing the variability to a baseline or a range; and estimating the disease state for the patient based upon the comparing of the variability to the baseline or the limit.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: September 20, 2022
    Assignee: Welch Allyn, Inc.
    Inventors: Steven D. Baker, Chau Chong Ye, Yue Wang, Aye Aung
  • Patent number: 11446484
    Abstract: Device (1) for electrotherapy and/or electrophysiology comprising at least one lead (2) having an elongated lead body extending along a longitudinal direction (X-X) and comprising a proximal end (3) and a distal end (4); and at least one paddle (5) having a paddle body comprising two opposite major surfaces (6, 7) defining a paddle thickness (33) there between; wherein said paddle (5) comprising at least one paddle electrode (8) having an exposed surface (9) designed to come into electrical contact with a living anatomy (10) inside a patient's body (11); said paddle (5) is suitable to modify the transverse encumber (12) thereof, so that to assume at least one transport configuration and at least one operative configuration, wherein the transverse encumber (12) of the paddle (5) when in said at least one transport configuration is less than the transverse encumber (12) of the same paddle (5) when in said at least one operative configuration; wherein said lead (2) comprising a connection portion (13) near the d
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: September 20, 2022
    Assignee: WISE SRL
    Inventors: Alessandro Antonini, Matteo Saini, Laura Spreafico, Sandro Ferrari, Sergio Malorni, Thomas Edward Parker, Georgina Rose Koffler, Caleb Luke Solomon
  • Patent number: 11433234
    Abstract: The current invention concerns a system and a method for the acute non-invasive treatment of a migraine attack. The system comprises at least one skin electrode for placement on the forehead of a patient. The system is configured for providing consecutive biphasic electrical pulses via said at least one skin electrode to the supratrochlear and supraorbital nerves of the ophthalmic branch of the trigeminal nerve during a prolonged time span. Preferably, the time span is at least 10 minutes.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: September 6, 2022
    Inventor: Pierre Rigaux
  • Patent number: 11420054
    Abstract: The present disclosure is directed to a system and method modulating targeted neural and non-neural tissue of a nervous system for the treatment of head-and-face pain. Electrical stimulation is delivered transcutaneously to the treatment site that modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting nervous signaling and the perception of pain.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: August 23, 2022
    Assignee: Avent, Inc.
    Inventors: David M. Page, Eric A. Schepis, Jalpa Shah, Natalia Alexeeva
  • Patent number: 11420043
    Abstract: A low-frequency treatment device includes a pad including a through hole and a pad side electrode on a rear surface, a holder disposed on the rear surface side of the pad so as to oppose the pad side electrode, a body including a body side electrode and detachably attached to the holder, and a wiring member configured to electrically connect the body side electrode and the pad side electrode. The wiring member includes a first end portion connected to the body side electrode, a second end portion connected to the pad side electrode, and a conductive portion, disposed such that a portion of the conductive portion extends through a through hole, for conducting electricity between the first end portion and the second end portion.
    Type: Grant
    Filed: August 28, 2019
    Date of Patent: August 23, 2022
    Assignee: OMRON HEALTHCARE CO., LTD.
    Inventors: Yoshiki Doi, Shinji Nakazawa
  • Patent number: 11420058
    Abstract: A system comprises a bendable, pre-formed lead body operable to be implanted proximate a neural pathway of a patient. A first electrode comprising a plurality of first segments at a first longitudinal location of the lead body is configured to be positioned at a lateral epidural region proximate at least one nerve root of the patient, and a second electrode comprising a plurality of second segments at a second longitudinal location of the lead body is configured to be positioned along a midline of the patient's spinal column. The system further includes a signal generator electrically coupled to at least one of the first and second electrodes and a processor coupled to the signal generator and operable to apply a stimulation signal to at least one of the first and second electrodes.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: August 23, 2022
    Assignee: Medtronic, Inc.
    Inventors: Andrew Jay Cleland, Melanie D. Goodman Keiser, Louis Vera-Portocarrero, Phillip C. Falkner, Brooke Kelley, Jiashu Li
  • Patent number: 11406306
    Abstract: This is directed to an electronic device having an integrated sensor for detecting a user's cardiac activity and cardiac electrical signals. The electronic device can include a heart sensor having several leads for detecting a user's cardiac signals. The leads can be coupled to interior surfaces of the electronic device housing to hide the sensor from view, such that electrical signals generated by the user can be transmitted from the user's skin through the electronic device housing to the leads. In some embodiments, the leads can be coupled to pads placed on the exterior of the housing. The pads and housing can be finished to ensure that the pads are not visibly or haptically distinguishable on the device, thus improving the aesthetic qualities of the device. Using the detected signals, the electronic device can identify or authenticate the user and perform an operation based on the identity of the user.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: August 9, 2022
    Assignee: Apple Inc.
    Inventors: Gloria Lin, Taido L. Nakajima, Pareet Rahul, Andrew B. Hodge
  • Patent number: 11406831
    Abstract: A terminal device includes: an information storage that stores registration information for establishing a wireless communication connection with an electrical treatment device; a detection unit that detects a beacon signal emitted from the electrical treatment device; a determination unit that determines, on the based on the registration information stored in the information storage unit and the beacon signal detect, whether the electrical treatment device includes an unregistered electrical treatment device. In a case where the unregistered electrical treatment device is included, the determination unit further determines, on the basis of the beacon signal detected, whether the unregistered electrical treatment device includes registration information of a device other than the terminal device.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: August 9, 2022
    Assignee: OMRON HEALTHCARE CO., LTD.
    Inventors: Yuka Kobayashi, Shozo Takamatsu, Tamaki Ito
  • Patent number: 11393571
    Abstract: Provided herein in some embodiments is a resistance-training system including an upper-body garment having a first section of a single-layered construction and a second section of a multi-layered construction. The single-layered construction can include a first fabric layer. The multi-layered construction can include the first fabric layer, a second fabric layer, and a resistance-providing layer in-between the first fabric layer and the second fabric layer. The resistance-training system also includes a lower-body garment having the multi-layered construction, optionally with a different resistance-providing layer than the upper-body garment. The resistance-providing layer of the upper-body garment and the lower-body garment can be configured to provide resistance to one or more user movements for a user donning the resistance-training system.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: July 19, 2022
    Inventor: Ryan K. Crume
  • Patent number: 11382566
    Abstract: Cardiac interventional devices are fitted with sensors coupled to an electrophysiology (EP) mapping system. The sensors can be in the form of electrodes and/or magnetic field sensors which are placed strategically upon the interventional devices. The interventional devices can thus be visualized on the EP mapping display when the interventional devices are being routed through various pathways adjacent to the heart of a patient. The interventional devices can include sheaths, and especially two part sheaths with a base separate from a tube, which base can be separated from the tube at an interface. Other interventional devices include an exoskeleton attachable to a lead, needles, guide wires, dilators, J wires and luminal catheters.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: July 12, 2022
    Inventor: Walter Kusumoto
  • Patent number: 11383086
    Abstract: In some examples, a medical device is configured to automatically determine a paresthesia threshold or a perception threshold of a patient in a second posture based on the paresthesia threshold or perception threshold of that patient in a first posture. The medical device may deliver an electrical stimulation signal to a patient and determine the paresthesia threshold or perception threshold for the patient in the first posture. The medical device may change the intensity of the electrical signal and receive an indication from the patient that they are experiencing paresthesia or perceiving the electrical stimulation signal. The medical device may then automatically determine a predicted paresthesia threshold or predicted perception threshold for a second posture based on the paresthesia threshold or perception threshold.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: July 12, 2022
    Assignee: Medtronic, Inc.
    Inventors: Lachlan Davies, Sheryl McCammon, Andrew J. Cleland, Melanie D Goodman Keiser, Ye Tan, Lisa M. Johanek, Nathan A. Torgerson